Increasing evidence has confirmed the efficacy of mTOR inhibitors in treating DN [192,193,194,195,196], although they may cause hyperglycemia due to the combination of impaired insulin secretion and insulin resistance [197]. The gene discussed is MTOR; the disease is liver dysplastic nodule.